Poolbeg Pharma PLC
POLB.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £9,961 | £7,824 | £10,061 | £12,171 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £738 | £519 | £11 | £700 |
| Inventory | £0 | £0 | £0 | £0 |
| Other Curr. Assets | £0 | £220 | £300 | £627 |
| Total Curr. Assets | £10,699 | £8,563 | £10,999 | £13,498 |
| Property Plant & Equip (Net) | £0 | £0 | £0 | £0 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £1,662 | £1,684 | £2,011 | £1,930 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £0 | £0 | £0 |
| Total NC Assets | £1,662 | £1,684 | £2,011 | £1,930 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £12,361 | £10,247 | £13,010 | £15,428 |
| Liabilities | – | – | – | – |
| Payables | £0 | £165 | £561 | £79 |
| Short-Term Debt | £0 | £0 | £0 | £0 |
| Tax Payable | £0 | £68 | £0 | £52 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £429 | £723 | £0 | -£52 |
| Total Curr. Liab. | £429 | £974 | £561 | £986 |
| LT Debt | £0 | £0 | £0 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £0 | £0 |
| Total NC Liab. | £0 | £0 | £0 | £0 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £429 | £974 | £561 | £986 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £139 | £100 | £100 | £100 |
| Retained Earnings | -£17,466 | -£16,743 | -£13,211 | -£9,498 |
| AOCI | £1,711 | £2,816 | £2,460 | £740 |
| Other Equity | £0 | £0 | £0 | £0 |
| Total Equity | £11,932 | £9,273 | £12,449 | £14,442 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £12,361 | £10,247 | £13,010 | £15,428 |
| Net Debt | -£9,961 | -£7,824 | -£10,061 | -£12,171 |